Paraovarian cystic endosalpingiosis in association with tamoxifen therapy

Journal of Clinical Pathology

Volumn 53, Issue 2, 2000, Pages 161-162

  McCluggage, W G ^a   Weir, P E ^a  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

Endosalpingiosis; Ovary; Paraovarian region; Tamoxifen

Indexed keywords

TAMOXIFEN;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER HORMONE THERAPY; CASE REPORT; CLINICAL FEATURE; CYST; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HORMONE DEPENDENCE; HUMAN; HUMAN TISSUE; PATHOGENESIS; PRIORITY JOURNAL; UTERINE TUBE DISEASE; UTERINE TUBE TUMOR;

ANTINEOPLASTIC AGENTS, HORMONAL; CYSTS; FALLOPIAN TUBE DISEASES; FEMALE; HUMANS; MIDDLE AGED; OVARIAN CYSTS; TAMOXIFEN;

EID: 0033979713     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.53.2.161     Document Type: Article

References (6)

1. 1 Zinsser KR. Endosalpingiosis in the omcntum. A study of autopsy and surgical material. Am J Surg Pathol 1982;6:109-17.
2. 2 Clement PB, Young RH. Florid cystic endosalpingiosis with tumor-like manifestations. A report of four cases including the first reported cases of transmural endosalpingiosis of the uterus. Am J Surg Pathol 1999;23:166-75.
3. 3 de Peralta MM, Delahoussaye PM, Tornos CS, et al. Benign retroperitoncal cysts of müllerian type: a clinicopathologic study of three cases and review of the literature. Int J Gynecol Pathol 1994;13:273-8.
4. 4 Ismail SM. Pathology of endometrium treated with tamoxifen. J Clin Pathol 1994;47:827-33.
5. 5 Cohen I, Beyth Y, Teppcr R, et al. Adenomyosis in postmenopausal breast-cancer patients treated with tamoxifen a new entity. Gynecol Oncol 1995;58:86-91.
6. 6 Ismajl SM, Maulik TG. Tamoxifen-associated postmenopausal endometriosis. Histopathology 1997;30:187-91.